Form 4 for AURA Aura Biosciences, Inc.
Accepted 2024-10-01 00:00:00 ET · period of report 2024-09-27 · accession 0000950170-24-110933 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-01 | 2024-09-27 | AURA | de los Pinos Elisabet | See Remarks, Dir | M - OptEx | $5.76 | +5,474 | 329.8K | +2% | +$31.5K |
| D | 2024-10-01 | 2024-09-27 | AURA | de los Pinos Elisabet | See Remarks, Dir | M - OptEx | $0.00 | -5,474 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-27 | M | A | 5,474 | $5.76 | 329,847 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-09-27 | M | D | 5,474 | $0.00 | 0 | D | $5.76 · — to 2024-10-01 | 5,474 Common Stock | (F3) This option is fully vested. |